Total Payments
$1,673
2020 Payments
$143.23
Companies
30
Transactions
117
Medicare Patients
1,876
Medicare Billing
$115,056
Payment Breakdown by Category
Food & Beverage$1,639 (97.9%)
Other$34.44 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,639 | 115 | 97.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34.44 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $521.14 | 44 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $136.45 | 8 | $0 (2019) |
| GlaxoSmithKline, LLC. | $118.48 | 8 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $78.59 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $76.82 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $69.22 | 5 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $67.99 | 5 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $66.91 | 5 | $0 (2019) |
| Allergan Inc. | $62.17 | 4 | $0 (2019) |
| AbbVie, Inc. | $55.02 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $143.23 | 10 | PFIZER INC. ($35.92) |
| 2019 | $431.29 | 33 | PFIZER INC. ($133.47) |
| 2018 | $541.39 | 39 | PFIZER INC. ($189.84) |
| 2017 | $557.09 | 35 | PFIZER INC. ($161.91) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular | ||||||
| 03/03/2020 | Medline Industries, Inc. | PluroGel Burn & Wound Dressings (Device), Hyalomatrix Wound Device | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Dermatology/Wound Care | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/18/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/11/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/05/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: VACCINES | ||||||
| 01/23/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: UROLOGY | ||||||
| 01/14/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: VACCINES | ||||||
| 01/07/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/25/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: VACCINES | ||||||
| 11/18/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ANTIBIOTICS | ||||||
| 11/12/2019 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $12.78 | General |
| Category: Endocrinology | ||||||
| 11/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2019 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: VACCINE | ||||||
| 09/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2019 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: Endocrinology | ||||||
| 08/26/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 480 | 540 | $72,234 | $22,136 |
| 2022 | 9 | 525 | 592 | $72,961 | $23,594 |
| 2021 | 9 | 381 | 423 | $57,282 | $33,508 |
| 2020 | 12 | 490 | 551 | $72,925 | $35,817 |
Total Patients
1,876
Total Services
2,106
Medicare Billing
$115,056
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 208 | $37,440 | $10,890 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 93 | $11,346 | $4,211 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $14,694 | $3,339 | 22.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 27 | $3,294 | $1,209 | 36.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,000 | $784.25 | 78.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,160 | $757.80 | 35.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $800.00 | $627.40 | 78.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 30 | $1,500 | $317.52 | 21.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $0.24 | $0.24 | 100.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $0.22 | $0.21 | 95.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 153 | $27,540 | $7,756 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 131 | $15,982 | $6,091 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $18,414 | $4,376 | 23.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 64 | 64 | $2,560 | $1,959 | 76.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 26 | $3,172 | $1,604 | 50.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,060 | $1,293 | 42.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 31 | $1,550 | $313.41 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 19 | $682.00 | $201.44 | 29.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 52 | 52 | $0.52 | $0.52 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 99 | 99 | $18,414 | $13,656 | 74.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 109 | $19,620 | $10,149 | 51.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 101 | $12,322 | $7,035 | 57.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 13 | $1,586 | $996.19 | 62.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,980 | $621.62 | 31.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 36 | 40 | $2,000 | $447.12 | 22.4% |
About Dr. Lola Mclaren Cevallos, MD
Dr. Lola Mclaren Cevallos, MD is a Internal Medicine healthcare provider based in E Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1518298272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lola Mclaren Cevallos, MD has received a total of $1,673 in payments from pharmaceutical and medical device companies, with $143.23 received in 2020. These payments were reported across 117 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($1,639).
As a Medicare-enrolled provider, Mclaren Cevallos has provided services to 1,876 Medicare beneficiaries, totaling 2,106 services with total Medicare billing of $115,056. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location E Greenwich, RI
- Active Since 01/20/2010
- Last Updated 04/04/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518298272
Products in Payments
- CHANTIX (Drug) $401.45
- SHINGRIX (Biological) $102.47
- INVOKANA (Drug) $91.72
- ENTRESTO (Drug) $69.22
- PREVNAR - 13 (Biological) $61.24
- TOUJEO (Drug) $61.14
- XARELTO (Drug) $44.73
- Creon (Drug) $43.67
- Myrbetriq (Drug) $41.27
- ZOSTAVAX (Biological) $39.97
- Mitigare (Drug) $37.54
- Baxdela (Drug) $35.56
- MYRBETRIQ (Drug) $35.55
- INBRIJA (Drug) $34.44
- NUEDEXTA (Drug) $32.21
- FARXIGA (Drug) $30.42
- VRAYLAR (Drug) $27.92
- PNEUMOVAX 23 (Biological) $26.94
- Tirosint (Drug) $26.02
- LOKELMA (Drug) $24.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.